Revvity Inc (RVTY)
116.42
-0.18
(-0.15%)
USD |
NYSE |
Jan 08, 16:00
116.00
-0.42
(-0.36%)
Pre-Market: 05:44
Revvity SG&A Expense (Quarterly): 239.48M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Bionano Genomics Inc | 9.464M |
| Bruker Corp | 238.50M |
| Azenta Inc | 72.01M |
| Harvard Bioscience Inc | 10.56M |
| Akoya Biosciences Inc | 14.67M |